ANKRD18A: A Potential Drug Target and Biomarker (G253650)

Target Name: ANKRD18A

NCBI ID: G253650

ANKRD18A

ANKRD18A: A Potential Drug Target and Biomarker

Ankyrin repeat domains (ANKRD) are a type of gene repeat that has been identified in a variety of organisms, including humans. These repeats are usually found at the C-terminus of proteins and are thought to play a role in protein stability and structure. One particular ANKRD, ANKRD18A, has been identified as a potential drug target and biomarker for several diseases.

The ANKRD18A gene is located on chromosome 18 and encodes a protein that is approximately 140 amino acids long. The protein has a unique structure that is composed of a variable region that includes an N-terminus, a single alpha-helicase domain, and a C-terminus that includes a series of ankyrin repeats. The ankyrin repeats are a unique feature of the ANKRD18A protein that sets it apart from other proteins.

The ankyrin repeats in ANKRD18A are thought to be involved in the stability and structure of the protein. These repeats are thought to contribute to the protein's stability by providing additional structural stability. Additionally, the ankyrin repeats may also play a role in the protein's interactions with other proteins.

The ANKRD18A protein has also been shown to be involved in several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, studies have shown that ANKRD18A is overexpressed in several types of cancer, including breast, ovarian, and colorectal cancer. This suggests that ANKRD18A may be a useful biomarker for these diseases.

In addition to its potential as a drug target, ANKRD18A has also been shown to be a potential biomarker for several other diseases. For example, studies have shown that ANKRD18A is overexpressed in individuals with Alzheimer's disease, a neurodegenerative disease. This suggests that ANKRD18A may be a useful biomarker for Alzheimer's disease.

Another study has shown that ANKRD18A is overexpressed in individuals with Parkinson's disease, a neurodegenerative disease that causes tremors and other motor symptoms. This suggests that ANKRD18A may be a useful biomarker for Parkinson's disease.

In addition to its potential as a drug target and biomarker, ANKRD18A is also thought to have potential therapeutic applications. For example, studies have shown that ANKRD18A can be targeted with small molecules to inhibit its activity. This suggests that ANKRD18A may be a useful target for new therapies.

Overall, ANKRD18A is a protein that has unique structure and is involved in several diseases. Its potential as a drug target and biomarker makes it an attractive target for further research and development. Further studies are needed to fully understand the role of ANKRD18A in disease and to develop new treatments.

Protein Name: Ankyrin Repeat Domain 18A

The "ANKRD18A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD18A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets